Instytut Biotechnologii i Badań Medycznych Biolamedsp. z o.o.
Research and experimental development on biotechnology
Overview
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 133 days early.
- 202519/03/2026
- 202421/03/2025
- 202315/03/2024
- 202217/03/2023
- 202121/03/2022
- 202024/03/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board – one member of the management board acting independently; in the case of a multi-member management board – each member of the management board acting independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Anna Danilczukage 44 | 1 | $337.66 | 25% |
Iwona Iwaniukage 48 | 1 | $337.66 | 25% |
Paweł Kitlas | 1 | $337.66 | 25% |
Agnieszka Zakrzeskaage 51 | 1 | $337.66 | 25% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2017-11-01.
54 1020 1332 0000 1402 1076 5057
Debt
No entries in the National Debtors Register (KRZ).
Public aid
10 public aid cases recorded, with a total value of $999,866.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 21, 2022 | Aid for research and development projects: industrial research | $191.1K$191,078 | Marszałek Województwa Podlaskiego | |
| Jan 21, 2022 | Aid for research and development projects: experimental development | $35,864$35,864 | Marszałek Województwa Podlaskiego | |
| Jan 21, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $9,007$9,007 | Marszałek Województwa Podlaskiego |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2022-01-21 | Conducting R&D work aimed at creating and marketing a hydrogel ointment to support wound healing for veterinary use | $235.9K$235,949 | Regional Operational Programme for Województwo Podlaskie for 2014-2020 | |
| 2018-08-14 | Establishment of R&D facilities and conducting R&D work aimed at implementing a range of medical products that accelerate wound healing, including wounds arising in the course of diabetes | $722.2K$722,167 | Regional Operational Programme for Województwo Podlaskie for 2014-2020 |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| Relvosp. z o.o. | $120,693.26 | relvo.pl | ||
| Microblicsp. z o.o. | $122,383.50 | microblic.pl | ||
| Biodecsp. z o.o. | $115,508.63 | biodec.pl | ||
| IntelliseqS.A. | $111,419.60 | intelliseq.pl | ||
| ModicaP.S.A. | $103,400.72 | modica.bio | ||
| Microbe Plussp. z o.o. | $104,197.26 | microbe-plus.com | ||
| WPD Pharmaceuticalssp. z o.o. | $90,822.78 | wpdpharmaceuticals.com | ||
| InventroS.A. | $12,176.61 | inventro.co | ||
| Plan Biosp. z o.o. | $3,404.49 | biotrem.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-01-09 | Address change (Ul. Przejazd 2a/107, 15-430, Białystok → Ul. Krakowska 9, 15-875, Białystok) | |
| 2017-09-29 | Entered in the register |
FAQ
Last updated: 2026-04-25